3 Undervalued Travel Stocks We Like
These names stand to benefit from a resumption of leisure travel -- and are all trading below our fair value estimates.
Fears surrounding the duration and severity of the coronavirus pandemic have weighed on travel stocks, creating opportunity for long-term investors. Today we’re looking at three of our favorite travel names.
Our first pick is Expedia (EXPE). While COVID-19 will stress Expedia's financial health in the near term, we think the firm will maintain its sizable network advantage over the long term once the virus is contained. True, Expedia faces elevated debt leverage in 2020, but we believe it has enough liquidity to operate under anemic demand conditions through 2021. We expect Expedia's network advantage to remain intact and possibly strengthen after the COVID-19 crisis, because we think smaller peers would be challenged to fund the substantial human and operational capital needed to replicate the company's platform. Further, Expedia's new management team is focused on reinvesting cost efficiency into loyalty and user experience, which should support its network advantage. We assign Expedia a narrow Economic Moat Rating and a $127 fair value estimate.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.